Earlier diagnosis of heart failure
Updated ESC (European Society of Cardiology) diagnostic algorithm aims to reduce the hospitalization rate.
There is a significant increase in diabetes mellitus worldwide, especially type 2 diabetes. This is associated with a significantly increased cardiovascular risk such as heart attacks, strokes and circulatory disorders in the legs. People with type 2 diabetes mellitus have several risk factors. In addition to hyperglycemia, visceral obesity, a lipid metabolism disorder and arterial hypertension can develop; all of which are associated with chronic, subclinical inflammation.
The focus of diabetes treatment is still on regulating blood glucose levels. Although this can prevent many complications, it has been shown that strict blood sugar control does not always lead to a better life expectancy.
It is now known that heart failure is a common complication of diabetes mellitus. It can have serious consequences and significantly impair the quality of life of those affected.
The blood marker CARDIAC NT-proBNP is becoming increasingly important for the early detection and treatment of heart failure in diabetics. This marker provides information about the strain on the heart and can help to identify an increased risk of heart failure at an early stage.
In line with the latest findings, the diagnostic algorithms of the specialist societies have been adapted and the new ESC heart failure guidelines stipulate that an NT-proBNP test should be performed in cases of suspected heart failure based on risk factors, symptoms and/or signs and an abnormal ECG.